Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
Home › Stocks › Semper Paratus Acquisition Corporation (LGST) Stock Forecast & Price Prediction United States | NASDAQ | Financial Services | Shell Companies
$1.23
+0.05 (4.24%)10 Quality Stocks Worth Considering Now
Researching Semper Paratus (LGST) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on LGST and similar high-potential opportunities.
LGST has shown a year-to-date change of 16.0% and a 1-year change of 50.0%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for LGST. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for LGST.
Date | Firm | Analyst | Rating | Change | Price Target |
---|
The following stocks are similar to Semper Paratus based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Semper Paratus Acquisition Corporation has a market capitalization of $67.36M with a P/E ratio of 50.1x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of +1.3%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Special purpose acquisition company targeting logistics industry.
The company operates as a special purpose acquisition company (SPAC) that aims to merge with or acquire businesses primarily in the transportation, supply chain, and logistics sectors. It generates revenue by taking companies public through mergers and benefiting from the subsequent market performance of those entities.
Incorporated in 2021 and based in New York, Semper Paratus Acquisition Corporation operates as a subsidiary of Ssvk Associates, LLC, which may provide strategic support and resources for its acquisition efforts.
Financial Services
Shell Companies
0
Mr. Surendra K. Ajjarapu
United States
2022
Tevogen Bio Holdings Inc. has completed its business combination with Semper Paratus Acquisition Corporation. Trading on Nasdaq under symbols TVGN and TVGNW starts February 15, 2024.
Tevogen Bio's merger and Nasdaq listing can enhance visibility and liquidity, attracting investor interest in its innovative immunotherapy developments. This may influence stock performance and market perception.
Semper Paratus Acquisition Corporation's shareholders approved the business combination with Tevogen Bio Inc. during a meeting on January 31, 2024.
Approval of the business combination signals potential growth and value creation for Semper Paratus and Tevogen Bio, impacting stock performance and investor sentiment.
Semper Paratus Acquisition Corp. has filed a Prospectus Supplement ahead of a shareholder meeting on Jan. 29, 2024, to vote on a merger with Tevogen Bio, resulting in a name change to Tevogen Bio Holdings Inc.
The filing indicates a significant merger that could reshape Semper Paratus, impacting stock value and investor sentiment as it transitions to Tevogen Bio Holdings.
Tevogen Bio and Semper Paratus Acquisition Corp. announced the SEC has approved their registration statement for a proposed business combination.
The SEC's approval of the registration statement signals progress in the merger, potentially increasing investor confidence and impacting stock prices for both companies.
Semper Paratus Acquisition Corporation (Nasdaq: LGST) has regained compliance with Nasdaq's MVLS Rule, maintaining a market value of listed securities over $50 million, ensuring its continued listing.
Regaining compliance with Nasdaq's MVLS rule ensures Semper Paratus can continue trading on the exchange, positively impacting investor confidence and stock stability.
Semper Paratus Acquisition Corp. filed a Form S-4 with the SEC for its proposed merger with Tevogen Bio Inc., a biotech firm focused on genetically unmodified T cell therapeutics.
The filing of a registration statement signals progress in Semper Paratus's merger with Tevogen Bio, potentially boosting investor confidence in the biotech's growth prospects.
Analyst forecasts for Semper Paratus Acquisition Corporation (LGST) are not currently available. The stock is trading at $1.23.
Analyst ratings for LGST are not currently available. The stock is currently trading at $1.23. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for LGST are not currently available. The stock is trading at $1.23.
The company operates as a special purpose acquisition company (SPAC) that aims to merge with or acquire businesses primarily in the transportation, supply chain, and logistics sectors. It generates revenue by taking companies public through mergers and benefiting from the subsequent market performance of those entities.
Price targets from Wall Street analysts for LGST are not currently available. The stock is trading at $1.23.
Price targets from Wall Street analysts for LGST are not currently available. The stock is trading at $1.23.
Analyst ratings for LGST are not currently available. The stock is trading at $1.23.
Stock price projections, including those for Semper Paratus Acquisition Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.